1887

Journal of General Virology header logo

Volume 79, Issue 12

Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity Free

Abstract

Equine herpesvirus-1 (EHV-1) causes rhino- pneumonitis, abortion and CNS disorders in horses. Using intranasal inoculation, the mouse model of this disease mimics the major pathogenic and clinical features of the equine disease. The aim of this study was to investigate whether murine dendritic cells (DC) can be infected with EHV-1 and whether they can be used as cellular vaccines for the induction of prophylactic anti-EHV-1 immunity. It was found that the DC lines FSDC, D2SC1, 18 (all H-2) and 80/1 (H-2), when incubated with the Ab4 strain of EHV-1, do not change their morphology and phenotype but sustain virus replication and induce proliferation of naive, syngeneic T cells. An even stronger proliferation of T cells was seen when DC were used that had been pre-exposed to heat-inactivated virus. DC lines were therefore pulsed with inactivated virus and were then administered intranasally to either BALB/c or C3H mice on days 25,15 and 5. Control groups received either medium, unpulsed DC or inactivated virus only. Animals were challenged with EHV-1. Whereas mice of control panels showed clinical signs of EHV-1 disease and 27 % died, animals immunized with the pulsed DC lines showed only subtle clinical symptoms, lost significantly less weight, exhibited a reduced virus load in their lungs and CNS and did not succumb to the disease during the observation period. These results show that murine DC can present EHV-1 and initiate a protective anti-viral immunity

  • Published Online:
© Society for General Microbiology 1998
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-12-3005
1998-12-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/12/9880015.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-12-3005&mimeType=html&fmt=ahah

References

  1. Alber D. G., Greensill J., Killington R. A., Stokes A. 1995; Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1)infection of C3H (H-2k) and BALB/c (H-2d) mice. Research in Veterinary Sciences 59:205–213
     [Google Scholar]
  2. Alderson M. R., Tough T. W., Ziegler S. F., Grabstein K. H. 1991; Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. Journal of Experimental Medicine 173:923–930
     [Google Scholar]
  3. Allen G., Yeargan M., Costa L. R., Cross R. 1995; Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. Journal of Virology 69:606–612
     [Google Scholar]
  4. Awan A. R., Chong Y. -C., Field H. J. 1990; The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. Journal of General Virology 71:1131–1140
     [Google Scholar]
  5. Azmi M., Field H. J. 1993a; Interactions between equine herpesvirus type 1 and equine herpesvirus type 4 : T cell responses in a murine infection model. . Journal of General Virology 74:2339–2345
     [Google Scholar]
  6. Azmi M., Field H. J. 1993b; Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells. Journal of General Virology 74:275–280
     [Google Scholar]
  7. Bachmann M. F., Lutz M. B., Layton G. T., Harris S. J., Fehr T., Rescigno M., Ricciardi-Castagnoli P. 1996; Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. European Journal of Immunology 26:2595–2600
     [Google Scholar]
  8. Bartels T., Steinbach F., Hahn G., Ludwig H., Borchers K. 1998; In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice. Immunology 93:329–334
     [Google Scholar]
  9. Baxi M. K., Borchers K., Bartels T., Schellenbach A., Baxi S., Field H. J. 1996; Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model. Virus Research 40:33–45
     [Google Scholar]
  10. Bender A., Bui L. K., Feldman M. A., Larsson M., Bhardwaj N. 1995; Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. Journal of Experimental Medicine 182:1663–1671
     [Google Scholar]
  11. Böhm W., Schirmbeck R., Elbe A., Melber K., Diminky D., Kraal G., van Rooijen N., Barenholz Y., Reimann J. 1995; Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. Journal of Immunology 155:3313–3321
     [Google Scholar]
  12. Chong Y. C., Duffus W. P. 1992; Immune responses of specific pathogen free foals to EHV-1 infection. Veterinary Microbiology 32:215–228
     [Google Scholar]
  13. Chong Y. C., Duffus W. P., Hannant D. 1992; Natural killer cells in normal horses and specific-pathogen-free foals infected with equine herpesvirus. Veterinary Immunology and Immunopathology 33:103–113
     [Google Scholar]
  14. Crabb B. S., Studdert M. J. 1995; Equine herpesvirus 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Advances in Virus Research 45:153–190
     [Google Scholar]
  15. Domke-Opitz I., Poberschin P., Mittnacht S., Kirchner H. 1987; Role of interferon in persistent infection of macrophages with herpes simplex virus. Virology 159:306–311
     [Google Scholar]
  16. Edens L. M., Crisman M. V., Toth T. E., Ahmed S. A., Murray M. J. 1996; In vitro cytotoxic activity of equine lymphocytes on equine herpesvirus-1 infected allogenic fibroblasts. Veterinary Immunology and Immunopathology 52:175–189
     [Google Scholar]
  17. Elbe A., Stingl G. 1995; Dendritic cells as stimulator cells of MHC class I-restricted immune responses. Advances of Experimental Medicine and Biology 378:341–345
     [Google Scholar]
  18. Elbe A., Schleischitz S., Strunk D., Stingl G. 1994; Fetal skin- derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells. Journal of Immunology 153:2878–2889
     [Google Scholar]
  19. Ferrari G., King K., Rathbun K., Place C. A., Packard M. V., Bartlett J. A., Bolognesi D. P., Weinhold K. J. 1995; IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clinical and Experimental Immunology 101:239–248
     [Google Scholar]
  20. Gibson J. S., Slater J. D., Awan A. R., Field H. J. 1992; Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Archives of Virology 123:351–366
     [Google Scholar]
  21. Girolomoni G., Lutz M. B., Pastore S., Assmann C. U., Cavani A., Ricciardi-Castagnoli P. 1995; Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. European Journal of Immunology 25:2163–2169
     [Google Scholar]
  22. Holt P. G., Haining S., Nelson D. J., Sedgwick J. D. 1994; Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. Journal of Immunology 153:256–261
     [Google Scholar]
  23. Hsu F. J., Benike C., Fagnoni F., Liles T. M., Czerwinski D., Taidi B., Engleman E. G., Levy R. 1996; Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nature Medicine 2:52–58
     [Google Scholar]
  24. Inazu M., Tsuha O., Kirisawa R., Kawakami Y., Iwai H. 1993; Equid herpesvirus 1 infection in mice. Journal of Veterinary Medical Sciences 55:119–121
     [Google Scholar]
  25. Jondal M., Schirmbeck R., Reimann J. 1996; MHC class I- restricted CTL responses to exogenous antigens. Immunity 5:295–302
     [Google Scholar]
  26. Kolesaric A., Stingl G., Elbe-Bürger A. 1997; MHC class I+/II- dendritic cells induce hapten specific immune responses in vitro and in vivo. Journal of Investigative Dermatology 109:580–585
     [Google Scholar]
  27. Kos F. J., Müllbacher A. 1992; Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7. European Journal of Immunology 22:3183–3185
     [Google Scholar]
  28. Kos F. J., Müllbacher A. 1993; IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. Journal of Immunology 150:387–393
     [Google Scholar]
  29. Lenz P., Elbe A., Stingl G., Bergstresser P. R. 1996; MHC class I expression on dendritic cells is sufficient to sensitize for transplantation immunity. Journal of Investigative Dermatology 107:844–848
     [Google Scholar]
  30. Leong K. H., Ramshaw I. A., Ramsey A. J. 1997; Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2- dependent manner. Viral Immunology 10:1–9
     [Google Scholar]
  31. Linnavouri K., Hovi T. 1983; Restricted replication of herpes simplex virus in human monocyte cultures : role of interferon. Virology 130:1–9
     [Google Scholar]
  32. Liu T., Zhou X., örrwell C., Lederer E., Ljundgren H. -G., Jondal M. 1995; Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses. Journal of Immunology 154:3147–3155
     [Google Scholar]
  33. Macatonia S. E., Taylor P. M., Knight S. C., Askonas B. A. 1988; Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. Journal of Experimental Medicine 169:1255–1264
     [Google Scholar]
  34. McWilliam A. S., Napoli S., Marsh A. M., Pemper F. L., Nelson D. J., Pimm C. L., Stumbles P. A., Wells T. N., Holt P. G. 1996; Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. Journal of Experimental Medicine 184:2429–2432
     [Google Scholar]
  35. Majordomo J. I., Zorina T., Storkus W. J., Zitvogel L., Celluzi C., Falo L. D., Melief C. J., Ildstad S. T., Kast W. M., Deleo A. B., Lotze M. T. 1995; Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Medicine 1:1297–1302
     [Google Scholar]
  36. Mehrotra P. T., Wu D., Crim J. A., Mostowski H. S., Siegel J. P. 1993; Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. Journal of Immunology 151:2444–2452
     [Google Scholar]
  37. Mehrotra P. T., Grant A. J., Siegel J. P. 1995; Synergistic effects of IL-7 and IL-12 on human T cell activation. Journal of Immunology 154:5093–5102
     [Google Scholar]
  38. Morahan P. S., Mama S., Anaraki F., Leary K. 1989; Molecular localization of abortive infection of resident peritoneal macrophages by herpes simplex virus type 1. Journal of Virology 63:2300–2307
     [Google Scholar]
  39. Nair S., Zhou F., Reddy R., Huang L., Rouse B. T. 1992; Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. Journal of Experimental Medicine 175:609–612
     [Google Scholar]
  40. Nair S., Babu J. S., Dunham R. G., Kanda P., Burke R. L., Rouse B. T. 1993; Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. Journal of Virology 67:4062–4069
     [Google Scholar]
  41. Osterrieder N., Wagner R., Brandmüller C., Schmidt P., Wolf H., Kaaden O. R. 1995; Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208:500–510
     [Google Scholar]
  42. Paglia P., Girolomoni G., Robbiati F., Granucci F., Ricciardi-Castagnoli P. 1993; Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. Journal of Experimental Medicine 178:1893–1901
     [Google Scholar]
  43. Paglia P., Chiodoni C., Rodolfo M., Colombo M. P. 1996; Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. Journal of Experimental Medicine 183:317–322
     [Google Scholar]
  44. Porgador A., Snyder D., Gilboa E. 1996; Induction of antitumor immunity using bone marrow-generated dendritic cells. Journal of Immunology 156:2918–2926
     [Google Scholar]
  45. Rock K. L. 1996; A new foreign policy: MHC class I molecules monitor the outside world. Immunology Today 17:131–137
     [Google Scholar]
  46. Schon-Hegrad M., Oliver J., McMenamin P. G., Holt P. G. 1991; Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. Journal of Experimental Medicine 173:1345–1356
     [Google Scholar]
  47. Semper A. E., Hartley J. A. 1996; Dendritic cells in the lung : what is their relevance to asthma?. Clinical and Experimental Allergy 26:485–490
     [Google Scholar]
  48. Slater J. D., Baxi M., Tewari D., Gibson J. S., Field H. J., Ludwig H., Steinbach F., Borchers K. 1994a; Experimental infection of specific pathogen-free ponies with equid herpesvirus-1 : detection of infectious virus and viral DNA. In Equine Infectious Diseases VII: pp. 255–260 edited by Nakajima H., Plowright W. Newmarket,UK: R & W Publications;
     [Google Scholar]
  49. Slater J. D., Borchers K., Thackray A. M., Field H. J. 1994b; The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. Journal of General Virology 75:2007–2016
     [Google Scholar]
  50. Smith C. A., Woodruff L. S., Kitchingman G. R., Rooney C. M. 1996; Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. Journal of Virology 70:6733–6740
     [Google Scholar]
  51. Steinman R. M. 1991; The dendritic cell system and its role in immunogenicity. Annual Review of Immunology 9:271–296
     [Google Scholar]
  52. Stokes A., Alber D. G., Cameron R. S., Marshall R. N., Allen G. P., Killington R. A. 1996; The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. Virus Research 44:97–109
     [Google Scholar]
  53. Telford E. A., Watson M. S., McBride K., Davison A. J. 1992; The DNA sequence of equine herpesvirus-1. Virology 189:304–316
     [Google Scholar]
  54. Tewari D., Whalley J. M., Love D. N., Field H. J. 1994; Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. Journal of General Virology 75:1735–1741
     [Google Scholar]
  55. Tewari D., Nair S. V., De Ungria M., Lawrence G. L., Hayden M., Love D. N., Field H. J., Whalley J. M. 1995; Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Archives of Virology 140:789–797
     [Google Scholar]
  56. van Snick J. 1990; Interleukin-6: an overview. Annual Review of Immunology 8:253–278
     [Google Scholar]
  57. Watts C. 1997; Capture and processing of exogenous antigens for presentation on MHC molecules. Annual Review of Immunology 15:821–850
     [Google Scholar]
  58. Welch P. A., Namen A. E., Goodwin R. G., Armitage R., Cooper M. D. 1989; Human IL-7: a novel T cell growth factor. Journal of Immunology 143:3562–3267
     [Google Scholar]
  59. Young J. W., Inaba K. 1996; Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. Journal of Experimental Medicine 183:7–11
     [Google Scholar]
  60. Yuspa S. H., Hawley-Nelson P., Koehler B., Stanley J. R. 1980; Asurvey of transformation markers in differentiating epidermal cell lines in culture. Cancer Research 40:4694–4703
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-12-3005
Loading
Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity
J. Gen. Virol. 79, 3005 (1998); https://doi.org/10.1099/0022-1317-79-12-3005
/content/journal/jgv/10.1099/0022-1317-79-12-3005
/content/journal/jgv/10.1099/0022-1317-79-12-3005
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error